Authors: Martel, JC Chopin, P Colpaert, F Marien, M

Citation: Jc. Martel et al., Drug treatments to reduce excitotoxicity in vivo: a potential for alpha 2-adrenoceptor antagonists?, AMINO ACIDS, 19(1), 2000, pp. 239-252

Authors: Mayer, P Brunel, P Chaplain, C Piedecoq, C Calmel, F Schambel, P Chopin, P Wurch, T Pauwels, PJ Marien, M Vidaluc, JL Imbert, T

Citation: P. Mayer et al., New substituted 1-(2,3-dihydrobenzo[1,4]dioxin-2-ylmethyl)piperidin-4-yl derivatives with alpha(2)-adrenoceptor antagonist activity, J MED CHEM, 43(20), 2000, pp. 3653-3664

Authors: John, GW Pauwels, PJ Perez, M Halazy, S Le Grand, B Verscheure, Y Valentin, JP Palmier, C Wurch, T Chopin, P Marien, M Kleven, MS Koek, W Assie, MB Carilla-Durand, E Tarayre, JP Colpaert, FC

Citation: Gw. John et al., F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine, J PHARM EXP, 290(1), 1999, pp. 83-95

Authors: Chopin, P Colpaert, FC Marien, M

Citation: P. Chopin et al., Effects of alpha-2 adrenoceptor agonists and antagonists on circling behavior in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway, J PHARM EXP, 288(2), 1999, pp. 798-804

Authors: Perez, M Pauwels, PJ Pallard-Sigogneau, I Fourrier, C Chopin, P Palmier, C Colovray, V Halazy, S

Citation: M. Perez et al., Design and synthesis of new potent, silent 5-HT1A antagonists by covalent coupling of aminopropanol derivatives with selective serotonin reuptake inhibitors, BIOORG MED, 8(23), 1998, pp. 3423-3428

Authors: Martel, JC Chopin, P Colpaert, F Marien, M

Citation: Jc. Martel et al., Neuroprotective effects of the alpha(2)-adrenoceptor antagonists, (+)-efaroxan and (+/-)-idazoxan, against quinolinic acid-induced lesions of the ratstriatum, EXP NEUROL, 154(2), 1998, pp. 595-601